Nov 02, 2021

Amarex Taiwan Exhibiting at BIO Asia-Taiwan 2021 | Nov. 4-7 | Taipei, Taiwan

​

Taipei, Taiwan (November 02, 2021) – We are pleased to announce that Amarex Taiwan, LLC is exhibiting at BIO Asia-Taiwan 2021, held November 4-7 at the Taipei Nangang Exhibition Center in Taiwan.

Sep 16, 2021

Amarex Passes Taiwan FDA GTP Audit: Result is a Resounding No Findings

​

Taipei, Taiwan (September 16, 2021) – Amarex Taiwan, LLC announces a no findings result of a Taiwan Food and Drug Administration (TFDA) audit of its office last month.

Feb 24, 2021

Amarex Featured in 15-year Anniversary Issue of the NSF International Journal

​

The just released Issue 48 of NSF International’s Health Science Journal features contributions by Amarex Clinical Research, LLC. This journal is available at https://www.nsf.org/periodicals/health-sciences-journal/issue-48.

Jan 18, 2021

Severe-to-Critical COVID-19 Patient Clinical Trial Reaches Full Enrollment

​

Our client’s Phase III clinical trial for patients with severe-to-critical COVID-19 symptoms reached full enrollment (390 patients) in mid-December. Data analysis results are expected this quarter. The trial was conducted in the U.S., Canada, and U.K..